Correlation of Growth Factor Receptor Expression with Clinical Growth in Vestibular Schwannomas
Authors:
- Brian F. OʼreillyBOBrian F. Oʼreilly
- Ameet KishoreAKAmeet Kishore
- John A. CrowtherJCJohn A. Crowther
- Colin SmithCSColin Smith
- 1 September 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 25 (5) , 791-796
Abstract
To examine the relationship between growth rate of vestibular schwannomas and the expression of various growth factor receptors. Retrospective case review of clinical growth rate in conjunction with a histopathologic and immunohistochemical reexamination of archival specimens. A tertiary referral neurotologic center. Three groups: a historical group to act as controls, consisting of 30 patients with sporadic vestibular schwannomas removed before the unit adopted an initial interval scan policy; a group of 14 patients with sporadic vestibular schwannomas who had undergone an initial interval scan policy, showed radiologic evidence of growth, and therefore had their schwannoma removed; and a group of 16 schwannomas removed from 11 neurofibromatosis Type 2 patients. A comparison between the three clinical groups using immunohistochemical studies to determine the level of expression of the proliferation factor Ki-67, c-erbB-2, and c-erbB-3 receptors and fibroblastic growth factor receptors 1 and 4. The level of expression of the proliferation factor Ki-67 was very low and similar in all three groups. C-erbB-2 and c-erbB-3 receptors were not expressed in any of the groups. fibroblastic growth factor receptor 4 expression was not significantly different, but there was a variation in the expression of fibroblastic growth factor receptor 1 between the three groups that correlated well with the differing incidence of growth in the groups. The increase in expression of fibroblastic growth factor receptor 1 in the neurofibromatosis Type 2 group was not statistically significant, but the increase in expression of fibroblastic growth factor receptor 1 in the growing sporadic group was statistically significant when compared with the historical controls. The level of fibroblastic growth factor receptor 1 expression correlates significantly with the rate of growth as measured on interval magnetic resonance imaging. Overexpression of fibroblastic growth factor receptor 1 has a positive correlation with the incidence and the rate of growth of sporadic vestibular schwannomas.Keywords
This publication has 20 references indexed in Scilit:
- Vestibular Schwannoma Growth: The Continuing ControversyThe Laryngoscope, 2000
- The conservative management of acoustic neuroma: a review of forty-four patients with magnetic resonance imagingClinical Otolaryngology, 2000
- Myelin Basic Protein and Myelin Basic Protein Peptides Induce the Proliferation of Schwann Cells Via Ganglioside GM1 and the FGF ReceptorNeurochemical Research, 1999
- Clinical experience with vestibular schwannomas: epidemiology, symptomatology, diagnosis, and surgical resultsEuropean Archives of Oto-Rhino-Laryngology, 1998
- Expression of Neuregulins and their Putative Receptors, ErbB2 and ErbB3, Is Induced during Wallerian DegenerationJournal of Neuroscience, 1997
- Growth Rate Characteristics of Acoustic Neuromas Associated With Neurofibromatosis Type 2The Laryngoscope, 1996
- The comparison between the growth fraction of bilateral vestibular schwannomas in neurofibromatosis 2 (NF2) and unilateral vestibular schwannomas using the monoclonal antibody MIB 1Acta Neurochirurgica, 1995
- Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2.Proceedings of the National Academy of Sciences, 1995
- Conservative Treatment of Patients with Acoustic TumorsNeurosurgery, 1991
- Workbook for MRI and CT of the head and neckAmerican Journal of Otolaryngology, 1989